Both in Pharmaceuticals
Corvus Pharmaceuticals vs Aktis Oncology
Over the past year CRVS returned +55.7% and AKTS returned −32.1%; their daily moves had a correlation of 0.09.
CRVS +55.7% AKTS −32.1%Growth of $1, one year, split-adjusted
| Metric | CRVS | AKTS |
|---|---|---|
| Price | $10.57 | $15.20 |
| Market cap | $889.2M | $845.4M |
| Today | +7.53% | +1.74% |
| 1 month | +0.1% | −14.9% |
| 6 months | −31.6% | −24.1% |
| Year to date | +37.3% | — |
| 1 year | +37.6% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −713.5% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $215.2M | $517.3M |
| Dividend yield | — | — |
| Volatility (60d) | 52.2% | 55.2% |
| Short % of float | 25.5% | 18.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).